Subscribe To
BCRX / Is BioCryst (BCRX) Ready to Breakout to New Highs on Recent Catalysts?
BCRX News
By Zacks Investment Research
September 19, 2023
BioCryst (BCRX) Surges 9.9%: Is This an Indication of Further Gains?
BioCryst (BCRX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revision more_horizontal
By Proactive Investors
September 18, 2023
BioCryst Pharmaceuticals rallies on Quebec reimbursement for Orladeyo angioedema treatment
BioCryst Pharmaceuticals (NASDAQ:BCRX) shares jumped in early Monday trading after it told investors that the Institut national d'excellence en santé more_horizontal
By Seeking Alpha
August 3, 2023
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 2023 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET Company Participants John Bluth - Investor Re more_horizontal
By GlobeNewsWire
May 31, 2023
BioCryst to Present New ORLADEYO® (berotralstat) Data at 2023 European Academy of Allergy and Clinical Immunology Congress
RESEARCH TRIANGLE PARK, N.C., May 31, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals Inc (Nasdaq: BCRX) today announced that the company will prese more_horizontal
By The Motley Fool
May 3, 2023
Why BioCryst Pharmaceuticals Stock Is Soaring Today
BioCryst Pharmaceuticals reported first-quarter earnings Wednesday morning. The financial report painted an overall encouraging picture regarding its more_horizontal
By GlobeNewsWire
April 19, 2023
BioCryst to Report First Quarter 2023 Financial Results on May 3
RESEARCH TRIANGLE PARK, N.C., April 19, 2023 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will more_horizontal
By Seeking Alpha
March 8, 2023
BioCryst: Good Candidate For Buyout, But Not For Anything Else
BioCryst Pharmaceuticals, Inc. has one blockbuster potential marketed drug, but not much of a pipeline. Last year, they shelved two separate programs more_horizontal
By The Motley Fool
February 22, 2023
Why Shares of BioCryst Pharmaceuticals Jumped Today
A day after the stock plummeted, it bounced back. more_horizontal